Glucocorticoid receptors in depression

C. M. Pariante, Charles Nemeroff, A. H. Miller

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

During major depression, dysfunction of limbic structures resulting in hypersecretion of corticotropin-releasing factor (CRF) is believed to cause the well-known hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this disorder. Nonsuppression of the HPA axis by dexamethasone in depressed patients suggests that this increased CRF secretion may be due, at least in part, to altered feedback inhibition by glucocorticoids. Because glucocorticoid-induced feedback inhibition of the HPA axis is mediated by glucocorticoid receptors (GRs) in the brain and pituitary, the possibility that depression is associated with a primary alteration in GRs number and/or function has been an important consideration regarding the pathophysiology of the depressive disorders. Nevertheless, studies investigating GRs kinetics in depressed patients have been inconsistent. In some studies, decreased GRs number in depressed patients has been observed; others have obtained discordant results. The inconsistency of results may be due to a number of factors, including patient heterogeneity, the cell populations sampled, and the methods used to determine receptors number. Fewer studies have investigated the functional sensitivity of cells to the inhibitory effects of glucocorticoids, but they have been more consistent, showing increased resistance of cells from depressed patients to the inhibitory effects of glucocorticoids on immune function. In view of intriguing data indicating monoamine regulation of GR number and function in a hormone independent fashion along with the well-known effects of glucocorticoids on behavior, further scrutiny of the role of GR in depression and its treatment is warranted.

Original languageEnglish
Pages (from-to)705-712
Number of pages8
JournalIsrael Journal of Medical Sciences
Volume31
Issue number12
StatePublished - Dec 1 1995
Externally publishedYes

Fingerprint

Glucocorticoid Receptors
Glucocorticoids
Depression
Corticotropin-Releasing Hormone
Feedback
Population Characteristics
Depressive Disorder
Dexamethasone
Brain
Cells
Hormones
Kinetics

Keywords

  • Adrenal hormones
  • Glucocorticoid receptor
  • Hypothalamic-pituitary-adrenal axis
  • Major depressive disorder

ASJC Scopus subject areas

  • Bioengineering
  • Medicine(all)

Cite this

Pariante, C. M., Nemeroff, C., & Miller, A. H. (1995). Glucocorticoid receptors in depression. Israel Journal of Medical Sciences, 31(12), 705-712.

Glucocorticoid receptors in depression. / Pariante, C. M.; Nemeroff, Charles; Miller, A. H.

In: Israel Journal of Medical Sciences, Vol. 31, No. 12, 01.12.1995, p. 705-712.

Research output: Contribution to journalArticle

Pariante, CM, Nemeroff, C & Miller, AH 1995, 'Glucocorticoid receptors in depression', Israel Journal of Medical Sciences, vol. 31, no. 12, pp. 705-712.
Pariante, C. M. ; Nemeroff, Charles ; Miller, A. H. / Glucocorticoid receptors in depression. In: Israel Journal of Medical Sciences. 1995 ; Vol. 31, No. 12. pp. 705-712.
@article{eecdd8db76704593a3befc9ceaf69a50,
title = "Glucocorticoid receptors in depression",
abstract = "During major depression, dysfunction of limbic structures resulting in hypersecretion of corticotropin-releasing factor (CRF) is believed to cause the well-known hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this disorder. Nonsuppression of the HPA axis by dexamethasone in depressed patients suggests that this increased CRF secretion may be due, at least in part, to altered feedback inhibition by glucocorticoids. Because glucocorticoid-induced feedback inhibition of the HPA axis is mediated by glucocorticoid receptors (GRs) in the brain and pituitary, the possibility that depression is associated with a primary alteration in GRs number and/or function has been an important consideration regarding the pathophysiology of the depressive disorders. Nevertheless, studies investigating GRs kinetics in depressed patients have been inconsistent. In some studies, decreased GRs number in depressed patients has been observed; others have obtained discordant results. The inconsistency of results may be due to a number of factors, including patient heterogeneity, the cell populations sampled, and the methods used to determine receptors number. Fewer studies have investigated the functional sensitivity of cells to the inhibitory effects of glucocorticoids, but they have been more consistent, showing increased resistance of cells from depressed patients to the inhibitory effects of glucocorticoids on immune function. In view of intriguing data indicating monoamine regulation of GR number and function in a hormone independent fashion along with the well-known effects of glucocorticoids on behavior, further scrutiny of the role of GR in depression and its treatment is warranted.",
keywords = "Adrenal hormones, Glucocorticoid receptor, Hypothalamic-pituitary-adrenal axis, Major depressive disorder",
author = "Pariante, {C. M.} and Charles Nemeroff and Miller, {A. H.}",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "31",
pages = "705--712",
journal = "Israel Medical Association Journal",
issn = "1565-1088",
publisher = "Israel Medical Association",
number = "12",

}

TY - JOUR

T1 - Glucocorticoid receptors in depression

AU - Pariante, C. M.

AU - Nemeroff, Charles

AU - Miller, A. H.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - During major depression, dysfunction of limbic structures resulting in hypersecretion of corticotropin-releasing factor (CRF) is believed to cause the well-known hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this disorder. Nonsuppression of the HPA axis by dexamethasone in depressed patients suggests that this increased CRF secretion may be due, at least in part, to altered feedback inhibition by glucocorticoids. Because glucocorticoid-induced feedback inhibition of the HPA axis is mediated by glucocorticoid receptors (GRs) in the brain and pituitary, the possibility that depression is associated with a primary alteration in GRs number and/or function has been an important consideration regarding the pathophysiology of the depressive disorders. Nevertheless, studies investigating GRs kinetics in depressed patients have been inconsistent. In some studies, decreased GRs number in depressed patients has been observed; others have obtained discordant results. The inconsistency of results may be due to a number of factors, including patient heterogeneity, the cell populations sampled, and the methods used to determine receptors number. Fewer studies have investigated the functional sensitivity of cells to the inhibitory effects of glucocorticoids, but they have been more consistent, showing increased resistance of cells from depressed patients to the inhibitory effects of glucocorticoids on immune function. In view of intriguing data indicating monoamine regulation of GR number and function in a hormone independent fashion along with the well-known effects of glucocorticoids on behavior, further scrutiny of the role of GR in depression and its treatment is warranted.

AB - During major depression, dysfunction of limbic structures resulting in hypersecretion of corticotropin-releasing factor (CRF) is believed to cause the well-known hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this disorder. Nonsuppression of the HPA axis by dexamethasone in depressed patients suggests that this increased CRF secretion may be due, at least in part, to altered feedback inhibition by glucocorticoids. Because glucocorticoid-induced feedback inhibition of the HPA axis is mediated by glucocorticoid receptors (GRs) in the brain and pituitary, the possibility that depression is associated with a primary alteration in GRs number and/or function has been an important consideration regarding the pathophysiology of the depressive disorders. Nevertheless, studies investigating GRs kinetics in depressed patients have been inconsistent. In some studies, decreased GRs number in depressed patients has been observed; others have obtained discordant results. The inconsistency of results may be due to a number of factors, including patient heterogeneity, the cell populations sampled, and the methods used to determine receptors number. Fewer studies have investigated the functional sensitivity of cells to the inhibitory effects of glucocorticoids, but they have been more consistent, showing increased resistance of cells from depressed patients to the inhibitory effects of glucocorticoids on immune function. In view of intriguing data indicating monoamine regulation of GR number and function in a hormone independent fashion along with the well-known effects of glucocorticoids on behavior, further scrutiny of the role of GR in depression and its treatment is warranted.

KW - Adrenal hormones

KW - Glucocorticoid receptor

KW - Hypothalamic-pituitary-adrenal axis

KW - Major depressive disorder

UR - http://www.scopus.com/inward/record.url?scp=0029565481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029565481&partnerID=8YFLogxK

M3 - Article

C2 - 8543464

AN - SCOPUS:0029565481

VL - 31

SP - 705

EP - 712

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

SN - 1565-1088

IS - 12

ER -